TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharma Production i Stockholm AB
Closing information (x1000 NOK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
12,419
|
11,843
|
11,823 |
Financial expenses |
0
![]() |
0
|
5 |
Earnings before taxes |
4,712
|
4,623
|
5,412 |
EBITDA |
4,635
|
4,650
|
5,433 |
Total assets |
6,463
|
4,228
|
4,326 |
Current assets |
6,354
|
4,087
|
4,240 |
Current liabilities |
3,502
|
860
|
981 |
Equity capital |
2,961
|
3,368
|
3,344 |
- share capital |
100
|
99
|
97 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
45.8%
|
79.7%
|
77.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
37.9%
|
39.0%
|
45.8% |
Return on assets (ROA) |
72.9%
|
109.3%
|
125.2% |
Current ratio |
181.4%
|
475.2%
|
432.2% |
Return on equity (ROE) |
159.1%
|
137.3%
|
161.8% |
Change turnover |
423
|
-236
|
-144 |
Change turnover % |
4%
|
-2%
|
-1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.